Ignite Creation Date:
2025-12-24 @ 12:31 PM
Ignite Modification Date:
2025-12-28 @ 10:52 AM
Study NCT ID:
NCT00209261
Status:
COMPLETED
Last Update Posted:
2011-05-19
First Post:
2005-09-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A 6-week Open Label Cross-over Study With 2 Different Daily Doses of Minirin® Oral Lyophilisate in Children and Adolescents With Primary Nocturnal Enuresis (PNE)
Sponsor:
Ferring Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
FE992026 CS022
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Clinical Development Support
Old Organization:
Ferring Pharmaceuticals